MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$20,837,628
Prepaid expenses and
other current assets
$1,219,809
Tax credits
$179,701
Operating lease
right-of-use assets
$334,090
Internal-use software, net
$102,837
Property and equipment,
net
$74,916
Restricted cash
$36,296
Long-term deposits and
other noncurrent...
$33,698
Total current assets
$22,237,138
Total noncurrent
assets
$581,837
Total assets
$22,818,975
Total liabilities and
stockholders' equity
$22,818,975
Total stockholders'
equity
$18,564,748
Total liabilities
$4,254,227
Accumulated deficit
-$81,194,908
Loss of the period
-$20,161,099
Additional paid-in capital
$119,139,677
Total current
liabilities
$3,352,396
Total noncurrent
liabilities
$901,831
Accumulated other
comprehensive income (loss)
$776,869
Common stock, 0.0001
par value...
$4,209
Other current
liabilities
$2,306,624
Accounts payable
$825,027
Operating lease
liabilities - current
$119,876
Loans - current
$100,869
Defined benefit pension
plan
$390,509
Loans - noncurrent
$300,084
Operating lease
liabilities - noncurrent
$211,238
Back
Back
Balance Sheet
source: myfinsight.com
Gain Therapeutics, Inc. (GANX)
Gain Therapeutics, Inc. (GANX)